Fujitsu Japan confirms the usefulness of exploring clinical trial candidate patients using AI and the US Paradigm platform
Fujitsu Japan, NCI Hospital East, and Paradigm confirmed the usefulness of AI and the Paradigm Platform for efficiently exploring clinical trial candidate patients.
Key points
- •The study utilized a large language model (LLM) and Paradigm's clinical trial matching platform, 'Paradigm Platform'.
- •A joint research project was conducted to support the exploration of candidate patients for new drug clinical trials.
- •They announced that the usefulness of significantly improving the efficiency of the exploration work was confirmed.